| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | CEO and President, Director | Common Stock | 636,149 | $515,281 | $0.8100 | 26 Aug 2021 | Direct |
| Aquestive Therapeutics, Inc. | CEO and President, Director | Common Stock | 1,000 | $810 | $0.8100 | 26 Aug 2021 | Custodian of UTMA account for Anna Kendall |
| Aquestive Therapeutics, Inc. | CEO and President, Director | Non-Qualified Stock Option (right to buy) | 375,000 | 10 Mar 2022 | Direct | ||
| FEMASYS INC | Director | Stock Option (Right to Buy) | 17,000 | 14 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FEMY | FEMASYS INC | 14 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 16:41 |
| FEMY | FEMASYS INC | 14 Jun 2023 | 0 | $0 | 3 | Director | 16 Jun 2023, 16:33 |
| AQST | Aquestive Therapeutics, Inc. | 10 Mar 2022 | 1 | $0 | 4 | CEO and President, Director | 14 Mar 2022, 11:24 |
| AQST | Aquestive Therapeutics, Inc. | 26 Aug 2021 | 2 | $0 | 4 | CEO and President, Director | 27 Aug 2021, 13:39 |